These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 6888453

  • 1. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W.
    N Engl J Med; 1983 Sep 29; 309(13):748-56. PubMed ID: 6888453
    [Abstract] [Full Text] [Related]

  • 2. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb 29; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 3. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar 29; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 4. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW, O'Neill BJ, Ogilvie RI, Beanlands DS, Tanser PH, Tihal H, Mizgala HF, Fitchett DH, Kostuk WJ.
    Can J Cardiol; 1991 Mar 29; 7(1):5-10. PubMed ID: 2025794
    [Abstract] [Full Text] [Related]

  • 5. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR.
    Clin Pharm; 1986 Mar 29; 5(3):201-5. PubMed ID: 3514085
    [Abstract] [Full Text] [Related]

  • 6. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA.
    Cardiology; 1992 Mar 29; 80(2):132-42. PubMed ID: 1611632
    [Abstract] [Full Text] [Related]

  • 7. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, Royal HD, Grossman W.
    Circulation; 1984 Dec 29; 70(6):1030-7. PubMed ID: 6499142
    [Abstract] [Full Text] [Related]

  • 8. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA, Ward A.
    Drugs; 1988 Aug 29; 36(2):158-92. PubMed ID: 3053125
    [Abstract] [Full Text] [Related]

  • 9. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P, Ramaprasad S.
    Pharmacotherapy; 1997 Aug 29; 17(2):371-4. PubMed ID: 9085331
    [Abstract] [Full Text] [Related]

  • 10. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA, Chatterjee K, Cody RJ, Kubo SH, Leonard D, Daly P, Rutman H.
    J Am Coll Cardiol; 1985 Aug 29; 6(2):453-9. PubMed ID: 4019930
    [Abstract] [Full Text] [Related]

  • 11. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, Le Jemtel TH.
    Circulation; 1983 May 29; 67(5):1065-70. PubMed ID: 6831672
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
    Anderson JL, Baim DS, Fein SA, Goldstein RA, LeJemtel TH, Likoff MJ.
    J Am Coll Cardiol; 1987 Apr 29; 9(4):711-22. PubMed ID: 3549837
    [Abstract] [Full Text] [Related]

  • 13. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS.
    Circulation; 1986 Jan 29; 73(1):130-7. PubMed ID: 3940664
    [Abstract] [Full Text] [Related]

  • 14. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES, Baim DS, Smith HS, Lanoue AS, Silverman KJ, Gervino EV, Grossman W.
    Circulation; 1986 Mar 29; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [Abstract] [Full Text] [Related]

  • 15. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
    Boesch C, Dubois-Rande JL, Pochmalicki G, Lellouche D, Teiger E, Saal JP, Cachin JC, Mallo C, Castaigne A, Jan F.
    Ann Cardiol Angeiol (Paris); 1992 Nov 29; 41(9):509-12. PubMed ID: 1298193
    [Abstract] [Full Text] [Related]

  • 16. Survival of patients with severe congestive heart failure treated with oral milrinone.
    Baim DS, Colucci WS, Monrad ES, Smith HS, Wright RF, Lanoue A, Gauthier DF, Ransil BJ, Grossman W, Braunwald E.
    J Am Coll Cardiol; 1986 Mar 29; 7(3):661-70. PubMed ID: 3950244
    [Abstract] [Full Text] [Related]

  • 17. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec 29; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 18. Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart.
    Piscione F, Jaski BE, Wenting GJ, Serruys PW.
    J Am Coll Cardiol; 1987 Dec 29; 10(6):1294-302. PubMed ID: 3680800
    [Abstract] [Full Text] [Related]

  • 19. Physiologic assessment of milrinone therapy in severe heart failure patients.
    Dubois-Randé JL, Duval-Moulin AM, Saal JP, Merlet P, Lellouche D, Deleuze P, Dupouy P, Brun P, Loisance D, Castaigne A.
    J Cardiovasc Pharmacol; 1991 Jun 29; 17(6):941-8. PubMed ID: 1714019
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
    Dubois-Randé JL, Guérot C, Jan F, Brochier M, Sacrez A, Vacheron A, Bory M, Lambert H, Pony JC, Le Bloc'h Y.
    Ann Cardiol Angeiol (Paris); 1993 Feb 29; 42(2):105-14. PubMed ID: 8494318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.